MSD has signed an agreement with Variational AI to use its generative AI (genAI) platform Enki in the discovery of new small-molecule medicines. Vancouver, Canada-based Variational – which emerged in ...
The UK government is reported to be trying to restart talks over drug pricing and rebates after MSD's shock decision to scrap a £1 billion investment programme. According to the Financial Times, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback